Perioperative Management of Clopidogrel

Standard Elective Surgery Protocol

The American Heart Association recommends discontinuing clopidogrel 5-7 days before elective surgery, with 7 days being preferable for optimal platelet recovery, particularly for CABG patients 1, 2
Discontinuing clopidogrel 5 days before elective surgery allows adequate platelet function recovery, as clopidogrel irreversibly inhibits platelet aggregation for the lifetime of the platelet (7-10 days) 1
Prasugrel requires 7 days of discontinuation before surgery due to its more potent and prolonged antiplatelet effects 3, 1
Ticagrelor requires only 5 days of discontinuation before surgery 3, 1

For urgent surgery where waiting 5 days is not feasible, discontinuing clopidogrel for at least 24 hours reduces major bleeding risk, though this carries increased bleeding risk compared to the full 5-day washout 1
Experienced surgeons may proceed with "early" CABG (within 5 days of clopidogrel) at acceptable incremental bleeding risk in urgent situations, though blood transfusion requirements increase 2

Patients at high risk for thrombotic events, such as those with drug-eluting stents placed within 12 months, bare-metal stents placed within 1 month, recent acute coronary syndrome, or recent stroke or TIA, should have elective procedures deferred until clopidogrel can be safely discontinued for the full 5-7 days 4, 5, 3
Cardiology consultation is mandatory before any clopidogrel interruption in high-risk patients to assess thrombotic versus bleeding risk 3

The American College of Cardiology recommends continuing aspirin throughout the perioperative period unless the bleeding risk is prohibitive, as aspirin alone poses minimal bleeding risk and provides critical cardiovascular protection 1, 4, 5
Stopping clopidogrel while continuing aspirin reduces bleeding risk while maintaining some cardiovascular protection in patients on dual antiplatelet therapy 4, 5

For procedures with high bleeding risk in closed spaces, such as neurosurgery, retinal surgery, or spinal procedures, the full 5-7 day discontinuation period is required without exception [6 is ignored, 8 is ignored, but 4 and 5 provide relevant information]
For endoscopic procedures with high bleeding risk, such as polypectomy, sphincterotomy, or endoscopic submucosal dissection, discontinuing clopidogrel for 7 days before the procedure is recommended, and aspirin should be continued if cardiovascular risk is high 4, 5

The 5-day discontinuation protocol is based on Class I, Level C evidence (expert consensus rather than randomized trials), but remains the standard of care endorsed by the American College of Cardiology and American Heart Association 1